Literature DB >> 15882167

Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade.

S Simaga1, M Osmak, D Babic, M Sprem, B Vukelic, M Abramic.   

Abstract

In an attempt to identify glycolytic capacity of normal and neoplastic human ovary, total lactate dehydrogenase (LDH) activity was measured in tissue cytosol originating from 69 patients (18 with benign ovarian tumor, 34 with ovarian carcinoma, six with nonepithelial ovarian malignant tumors, and 11 with tumor metastatic to ovary) and compared to the LDH activity of normal ovarian tissues (n = 19). Median value of total LDH-specific activity expressed as U/mg protein was 0.546 in normal tissues, 0.584 in benign tumors, 1.071 in malignancies metastatic to ovaries, 0.872 in nonepithelial primary ovarian tumors, and 0.818 in primary carcinomas. A significant rise in LDH-specific activity was found in malignant primary and secondary tumors of epithelial and nonepithelial origin, but not in benign neoplasms, compared to the activity in normal tissue. Ovarian carcinomas of serous histologic type did not differ in LDH activity from mucinous tumors. However, poorly differentiated carcinomas (grade 3) showed significantly enhanced activity of this glycolytic enzyme when compared to its grade 1 counterpart. The subgroup of grade 1 tumors did not differ in LDH activity from normal and benign ovarian tissue. Obtained results suggest that direct correlation might exist between ovarian epithelial tumor grade and lactate dehydrogenase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882167     DOI: 10.1111/j.1525-1438.2005.14410.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Therapeutic potential of riboflavin, niacin and ascorbic acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.

Authors:  Sengodan Sundravel; Palanivel Shanthi; Panchanadham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

2.  A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Authors:  Hsin-Yao Tang; Lynn A Beer; Tony Chang-Wong; Rachel Hammond; Phyllis Gimotty; George Coukos; David W Speicher
Journal:  J Proteome Res       Date:  2011-11-18       Impact factor: 4.466

3.  Upregulation of HO-1 Attenuates LPS-Stimulated Proinflammatory Responses Through Downregulation of p38 Signaling Pathways in Rat Ovary.

Authors:  Lian Li; Juan Tang; Yu Sun; Jie Wu; Pan Yu; Genlin Wang
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

4.  Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.

Authors:  Céline Pinheiro; Rui M Reis; Sara Ricardo; Adhemar Longatto-Filho; Fernando Schmitt; Fátima Baltazar
Journal:  J Biomed Biotechnol       Date:  2010-05-04

5.  Examination of viability and quality of ovarian tissue after cryopreservation using simple laboratory methods in ewe.

Authors:  Ghaya Merdassi; Claire Mazoyer; Jean F Guerin; Ali Saad; Bruno Salle; Jacqueline Lornage
Journal:  Reprod Biol Endocrinol       Date:  2011-06-08       Impact factor: 5.211

6.  JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.

Authors:  Haifeng Qiu; Amanda L Jackson; Joshua E Kilgore; Yan Zhong; Leo Li-Ying Chan; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Oncotarget       Date:  2015-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.